Taichu Biotechnology
About Taichu Biotechnology
Taichu Biotechnology is a contract research organization (CRO) specializing in nonclinical research for novel medications, utilizing methods such as pharmacokinetics, in vivo efficacy testing, and toxicology assessments. The company provides essential early-stage drug development services to pharmaceutical firms, facilitating the transition from laboratory research to clinical trials.
```xml <problem> Pharmaceutical companies require comprehensive nonclinical research services to evaluate the safety and efficacy of novel drug candidates before advancing to human clinical trials. These services, including pharmacokinetics, toxicology, and in vivo efficacy testing, are critical for identifying potential risks and optimizing drug development strategies. </problem> <solution> Taichu Biotechnology is a contract research organization (CRO) that provides integrated nonclinical research services to support the development of innovative drugs. The company offers a range of services, including early drug screening, pharmacodynamics studies, pharmacokinetic studies, and nonclinical safety evaluations. Taichu Biotechnology utilizes advanced technologies and methodologies to assess drug efficacy, toxicity, and pharmacokinetic properties in preclinical models, helping pharmaceutical companies make informed decisions and accelerate drug development. </solution> <features> - In vitro and in vivo drug efficacy screening using enzyme, cell, organ, tissue, and animal models - Early pharmacokinetic screening using ELISA, LC/MS, and HPLC to assess bioavailability and metabolic properties - Early toxicity screening, including high-throughput genotoxicity, cardiotoxicity, and carcinogenicity assays - Pharmacodynamic studies, including cell proliferation, antiviral, antibacterial, target binding, and mechanism of action studies - Pharmacokinetic studies, including absorption, distribution, metabolism, and excretion (ADME) profiling for small and large molecules - Nonclinical safety evaluations, including single and repeat-dose toxicity studies, safety pharmacology studies, and genotoxicity studies - Specialized facilities including a 3500m² conventional animal facility and a 3000m² SPF barrier facility with A-BSLII animal rooms - Comprehensive bioanalytical services, clinical pathology, molecular and cell biology, and BSLII standard biosafety laboratories </features> <target_audience> Taichu Biotechnology serves pharmaceutical companies and drug development organizations seeking comprehensive nonclinical research services to support the development of novel therapeutics. </target_audience> ```
What does Taichu Biotechnology do?
Taichu Biotechnology is a contract research organization (CRO) specializing in nonclinical research for novel medications, utilizing methods such as pharmacokinetics, in vivo efficacy testing, and toxicology assessments. The company provides essential early-stage drug development services to pharmaceutical firms, facilitating the transition from laboratory research to clinical trials.
Where is Taichu Biotechnology located?
Taichu Biotechnology is based in Shanghai, China.
When was Taichu Biotechnology founded?
Taichu Biotechnology was founded in 2020.
- Location
- Shanghai, China
- Founded
- 2020 0